Xeptiva Therapeutics

Xeptiva is a biotechnology company developing therapies for the treatment of chronic inflammation in companion animals

Business Model:

Revenue: $0

Employees: 1-10

Detailed Xeptiva Therapeutics Information

Geographic Data

Xeptiva Therapeutics headquarters map

Address:

City: Montevideo

State: NA - Uruguay

Zip:

Country: Uruguay

Financial Info

Stage:

pre seed

Raised Last:

$500k

Raised Total:

$500k

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Xeptiva Therapeutics is a veterinary biotechnology company that focuses on developing therapies for chronic inflammation conditions in companion animals. Its main products target chronic pain associated with osteoarthritis and atopic dermatitis in dogs. In addition, the company is developing therapies for the treatment of pain in horses and asthma in cats. Xeptiva&s;s goal is to allow pets to live longer and healthier by targeting the underlying source of many chronic diseases.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2021 Pre Seed Round $500k
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research